This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to outcomesrocket.com

The key to improving patient outcomes and lowering healthcare costs lies in effectively integrating genomic insights into clinical decision-making. 

In this episode, Surya Singh, CEO of InformedDNA, discusses how his company uses technology and genetic information to enhance population health. He shares the recent acquisition of Coriell Life Sciences, a pharmacogenomics company, to expand its proactive healthcare capabilities. With a background as a physician and healthcare strategist, Surya emphasizes the importance of shifting from reactive to preventive care. He also highlights the launch of DNA Impact, a population health platform designed to identify and support at-risk individuals by streamlining the genetic testing process and addressing the underutilization of validated genetic assessments.

Tune in and learn how genomic solutions can revolutionize healthcare and improve patient outcomes!

Fast Track Your Business Growth:

Outcomes Rocket is a full-service marketing agency focused on helping healthcare organizations like yours maximize your impact and accelerate growth. Learn more at outcomesrocket.com